Marc Odrich
Vermogen: 569 147 $ op 30-06-2026
Vermogen: 569 147 $ op 30-06-2026
Marc Odrich is currently Chief Medical Officer & Director at TearSolutions, Inc., Director at CXL Ophthalmics LLC, Associate Professor at the University of Virginia, and Chief Medical Officer at LENZ Therapeutics, Inc. Formerly, Dr. Odrich was Medical Director at VISX, Inc. Education includes a doctorate from Columbia University College of Physicians & Surgeons.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
0,32% | 14-04-2026 | 100.202 ( 0,32% ) | 569 147 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
TearSolutions, Inc.
TearSolutions, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops natural tear generation therapy for dry eyes | Corporate Officer/Principal | - |
CXL Ophthalmics LLC
CXL Ophthalmics LLC Medical/Nursing ServicesHealth Services Develops a treatment for eyecare | Directeur/Bestuurslid | - |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| Bedrijven | Functie | Einde |
|---|---|---|
VISX, Inc. | Hoofd Techniek/Wetenschap/O&O | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia University College of Physicians & Surgeons
Columbia University College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TearSolutions, Inc.
TearSolutions, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops natural tear generation therapy for dry eyes | Health Technology |
VISX, Inc. | |
CXL Ophthalmics LLC
CXL Ophthalmics LLC Medical/Nursing ServicesHealth Services Develops a treatment for eyecare | Health Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau